Literature DB >> 10021386

Transformation mediated by RhoA requires activity of ROCK kinases.

E Sahai1, T Ishizaki, S Narumiya, R Treisman.   

Abstract

BACKGROUND: The Ras-related GTPase RhoA controls signalling processes required for cytoskeletal reorganisation, transcriptional regulation, and transformation. The ability of RhoA mutants to transform cells correlates not with transcription but with their ability to bind ROCK-I, an effector kinase involved in cytoskeletal reorganisation. We used a recently developed specific ROCK inhibitor, Y-27632, and ROCK truncation mutants to investigate the role of ROCK kinases in transcriptional activation and transformation.
RESULTS: In NIH3T3 cells, Y-27632 did not prevent the activation of serum response factor, transcription of c-fos or cell cycle re-entry following serum stimulation. Repeated treatment of NIH3T3 cells with Y-27632, however, substantially disrupted their actin fibre network but did not affect their growth rate. Y-27632 blocked focus formation by RhoA and its guanine-nucleotide exchange factors Dbl and mNET1. It did not affect the growth rate of cells transformed by Dbl and mNET1, but restored normal growth control at confluence and prevented their growth in soft agar. Y-27632 also significantly inhibited focus formation by Ras, but had no effect on the establishment or maintenance of transformation by Src. Furthermore, it significantly inhibited anchorage-independent growth of two out of four colorectal tumour cell lines. Consistent with these data, a truncated ROCK derivative exhibited weak ability to cooperate with activated Raf in focus formation assays.
CONCLUSIONS: ROCK signalling is required for both the establishment and maintenance of transformation by constitutive activation of RhoA, and contributes to the Ras-transformed phenotype. These observations provide a potential explanation for the requirement for Rho in Ras-mediated transformation. Moreover, the inhibition of ROCK kinases may be of therapeutic use.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10021386     DOI: 10.1016/s0960-9822(99)80067-0

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  66 in total

1.  Post-transcriptional down-regulation of ROCKI/Rho-kinase through an MEK-dependent pathway leads to cytoskeleton disruption in Ras-transformed fibroblasts.

Authors:  Geraldine Pawlak; David M Helfman
Journal:  Mol Biol Cell       Date:  2002-01       Impact factor: 4.138

2.  The insert region of RhoA is essential for Rho kinase activation and cellular transformation.

Authors:  H Zong; K Kaibuchi; L A Quilliam
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

3.  Ezrin function is required for ROCK-mediated fibroblast transformation by the Net and Dbl oncogenes.

Authors:  C Tran Quang; A Gautreau; M Arpin; R Treisman
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

4.  Physical and functional interactions of Galphaq with Rho and its exchange factors.

Authors:  S A Sagi; T M Seasholtz; M Kobiashvili; B A Wilson; D Toksoz; J H Brown
Journal:  J Biol Chem       Date:  2001-02-06       Impact factor: 5.157

5.  TGF-beta-induced RhoA and p160ROCK activation is involved in the inhibition of Cdc25A with resultant cell-cycle arrest.

Authors:  Neil A Bhowmick; Mayshan Ghiassi; Mary Aakre; Kimberly Brown; Vikas Singh; Harold L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

6.  Involvement of Rho family GTPases in p19Arf- and p53-mediated proliferation of primary mouse embryonic fibroblasts.

Authors:  Fukun Guo; Yi Zheng
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

7.  RhoE inhibits cell cycle progression and Ras-induced transformation.

Authors:  Priam Villalonga; Rosa M Guasch; Kirsi Riento; Anne J Ridley
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

8.  Rac-dependent doubling of HeLa cell area and impairment of cell migration and cell cycle by compounds from Iris germanica.

Authors:  Michal Halpert; Mohamad Abu-Abied; Dror Avisar; Yoni Moskovitz; Osnat Altshuler; Avner Cohen; Mira Weissberg; Joseph Riov; Hugo E Gottlieb; Avichai Perl; Einat Sadot
Journal:  Protoplasma       Date:  2011-01-05       Impact factor: 3.356

9.  Effect of ROCK inhibitor Y-27632 on normal and variant human embryonic stem cells (hESCs) in vitro: its benefits in hESC expansion.

Authors:  Kalamegam Gauthaman; Chui-Yee Fong; Ariff Bongso
Journal:  Stem Cell Rev Rep       Date:  2009-12-15       Impact factor: 5.739

10.  Constitutively active RhoA inhibits proliferation by retarding G(1) to S phase cell cycle progression and impairing cytokinesis.

Authors:  Pierre Morin; Cristina Flors; Michael F Olson
Journal:  Eur J Cell Biol       Date:  2009-06-09       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.